Zobrazeno 1 - 10
of 269
pro vyhledávání: '"Antonio, Silvani"'
Autor:
Elena Anghileri, Irene Tramacere, Sara Morlino, Catia Leuzzi, Lorena Pareja Gutierrez, Saba Motta, Antonio Silvani, Anna Amato, Francesca Romana Berrini
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 3895-3907 (2024)
Objective: The COVID-19 pandemic affected neuro-oncological patients and their caregivers regarding tumor care and emotional functioning, including Quality of Life (QoL). This study aimed to understand how COVID-19 affected their psychological state
Externí odkaz:
https://doaj.org/article/4d4fbfcdce9640758d257daa9534a48b
Autor:
Michele Basile, Ilaria Valentini, Roberto Attanasio, Renato Cozzi, Agnese Persichetti, Irene Samperi, Alessandro Scoppola, Renata Simona Auriemma, Ernesto De Menis, Felice Esposito, Emanuele Ferrante, Giuseppe Iatì, Diego Mazzatenta, Maurizio Poggi, Roberta Rudà, Fabio Tortora, Fabio Cruciani, Zuzana Mitrova, Rosella Saulle, Simona Vecchi, Paolo Cappabianca, Agostino Paoletta, Alessandro Bozzao, Marco Caputo, Francesco Doglietto, Francesco Ferraù, Andrea Gerardo Lania, Stefano Laureti, Stefano Lello, Davide Locatelli, Pietro Maffei, Giuseppe Minniti, Alessandro Peri, Chiara Ruini, Fabio Settanni, Antonio Silvani, Nadia Veronese, Franco Grimaldi, Enrico Papini, Americo Cicchetti
Publikováno v:
Global & Regional Health Technology Assessment, Vol 11, Iss 1 (2024)
Background: Prolactinoma, the most common pituitary adenoma, is usually treated with dopamine agonist (DA) therapy like cabergoline. Surgery is second-line therapy, and radiotherapy is used if surgical treatment fails or in relapsing macroprolactinom
Externí odkaz:
https://doaj.org/article/be7a7f4d80ca47729a7554b777158858
Autor:
Andrea Pace, Giuseppe Lombardi, Veronica Villani, Dario Benincasa, Claudia Abbruzzese, Ilaria Cestonaro, Martina Corrà, Marta Padovan, Giulia Cerretti, Mario Caccese, Antonio Silvani, Paola Gaviani, Diana Giannarelli, Gennaro Ciliberto, Marco G. Paggi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionDrug repurposing is a promising strategy to develop new treatments for glioblastoma. In this phase II clinical trial, we evaluated the addition of chlorpromazine to temozolomide in the adjuvant phase of the standard first-line therapeutic
Externí odkaz:
https://doaj.org/article/1777b3e624694358a3da7950b2868a0c
Autor:
Ana Belén Díaz Méndez, Andrea Sacconi, Elisa Tremante, Valentina Lulli, Valentina Caprara, Laura Rosanò, Frauke Goeman, Mariantonia Carosi, Marta Di Giuliani, Giulia Vari, Antonio Silvani, Bianca Pollo, Carlo Garufi, Sara Ramponi, Giorgia Simonetti, Emilio Ciusani, Chiara Mandoj, Stefano Scalera, Veronica Villani, Agnese Po, Elisabetta Ferretti, Giulia Regazzo, Maria Giulia Rizzo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-15 (2023)
Abstract Background Altered microRNA profiles have been observed not only in tumour tissues but also in biofluids, where they circulate in a stable form thus representing interesting biomarker candidates. This study aimed to identify a microRNA signa
Externí odkaz:
https://doaj.org/article/9df0a57abcaa4378a24a3156271a698c
Autor:
Fabiola Silvaggi, Matilde Leonardi, Alberto Raggi, Michela Eigenmann, Arianna Mariniello, Antonio Silvani, Elena Lamperti, Silvia Schiavolin
Publikováno v:
Frontiers in Human Neuroscience, Vol 14 (2020)
Brain tumors (BT) are between the eight most common cancers among persons aged 40 years, with an average survival time of 10 years for patients affected by non-malignant brain tumor. Some patients continue to work, reporting difficulties in work-rela
Externí odkaz:
https://doaj.org/article/bce25be34d0b4c6b86fcbec39700ab0c
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2018)
We describe the 20-year course of a 63-year-old male with a macroprolactinoma that acquired resistance to treatment and aggressive behavior after a 4-year successful treatment with cabergoline. He was submitted to multiple surgical resections by a sk
Externí odkaz:
https://doaj.org/article/2291a8a4fd314432a9fcad92c2eab12d
Autor:
Raffaele Addeo, Giuseppe Lamberti, Giorgia Simonetti, Patrizia Iodice, Alfredo Marinelli, Liliana Montella, Salvatore Cappabianca, Paola Gaviani, Michele Caraglia, Salvatore Del Prete, Antonio Silvani
Publikováno v:
CNS Oncology, Vol 8, Iss 2 (2019)
Aim: To assess the efficacy and safety of alternative fotemustine administration schedule in elderly patients with recurrent glioblastoma. Patients & methods: Patients aged >65 years with recurrent glioblastoma received fotemustine (80 mg/m2; days 1,
Externí odkaz:
https://doaj.org/article/73203f976b0042d79d481f1e7470e992
Autor:
Roberto Attanasio, Renato Cozzi, Renata Simona Auriemma, Ernesto De Menis, Felice Esposito, Emanuele Ferrante, Giuseppe Iatì, Diego Mazzatenta, Maurizio Poggi, Roberta Rudà, Fabio Tortora, Fabio Cruciani, Zuzana Mitrova, Rosella Saulle, Simona Vecchi, Michele Basile, Paolo Cappabianca, Agostino Paoletta, Enrico Papini, Agnese Persichetti, Irene Samperi, Alessandro Scoppola, Alessandro Bozzao, Marco Caputo, Francesco Doglietto, Francesco Ferraù, Andrea Gerardo Lania, Stefano Laureti, Stefano Lello, Davide Locatelli, Pietro Maffei, Giuseppe Minniti, Alessandro Peri, Chiara Ruini, Fabio Settanni, Antonio Silvani, Nadia Veronese, Franco Grimaldi
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 23
Introduction: This guideline (GL) is aimed at providing a reference for the management of prolactin (PRL)-secreting pituitary adenoma in adults. However, pregnancy is not considered. Methods: This GL has been developed following the methods described
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c635c408ae209950b4627b5e69c73fbe
https://doi.org/10.2174/1871530323666230511104045
https://doi.org/10.2174/1871530323666230511104045
Autor:
Andrea Botturi, Antonio Silvani, Gabriella Pravettoni, Riccardo Augusto Paoli, Claudio Lucchiari
Publikováno v:
Case Reports in Neurology, Vol 8, Iss 2, Pp 115-119 (2016)
Neurological and psychiatric conditions frequently overlap in neuro-oncology. This overlapping negatively affects patients’ quality of life and decreases the ability of providers to manage specific symptoms by therapy modulation, especially when ps
Externí odkaz:
https://doaj.org/article/e9f87b8dd65b412a9aa62fbb44c93486
Autor:
A Bersani, Maura Lusignani, Antonio Silvani, Irene Tramacere, Paola Gaviani, Giorgia Simonetti
Publikováno v:
Journal of Vascular Nursing. 40:11-16
Objective Peripherally inserted central catheters (PICC) guarantee a stable and safe vascular access to administer irritants or vesicants therapies. However, they may occasionally be affected by relevant thrombotic complications especially in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96eeebff66e186fa346b8f6fd162c75f
https://doi.org/10.1016/j.jvn.2021.10.001
https://doi.org/10.1016/j.jvn.2021.10.001